Evidence map›Paper›PMID 28659859›Full record

ArticleFrontiers in neurology2017

Pre-Stroke Modified Rankin Scale: Evaluation of Validity, Prognostic Accuracy, and Association with Treatment.

Terence J Quinn, Martin Taylor-Rowan, Aishah Coyte, Allan B Clark, Stanley D Musgrave, Anthony K Metcalf, Diana J Day, Max O Bachmann, Elizabeth A Warburton, John F Potter and 1 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Reperfusion therapies for ischemic stroke in dementia and cognitive impairment: A systematic review and meta-analysis.International journal of stroke : official journal of the International Stroke Society · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Observational
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Terence J QuinnInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Martin Taylor-RowanInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Aishah CoyteInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Allan B ClarkNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Stanley D MusgraveNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Anthony K MetcalfStroke Research Group, Norfolk and Norwich University Hospital, Norwich, United Kingdom.
Diana J DayLewin Stroke & Rehabilitation Unit, Addenbrooke's Hospital, Cambridge, United Kingdom.
Max O BachmannNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Elizabeth A WarburtonLewin Stroke & Rehabilitation Unit, Addenbrooke's Hospital, Cambridge, United Kingdom.
John F PotterNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Phyo Kyaw MyintNorwich Medical School, University of East Anglia, Norwich, United Kingdom.

Funding

Department of Health PB-PG-1208-18240
6 · The paper itself

Abstract

background and purposeThe modified Rankin Scale (mRS) was designed to measure poststroke recovery but is often used to describe pre-stroke disability. We sought to evaluate three aspects of pre-stroke mRS: validity as a measure of pre-stroke disability; prognostic accuracy and association of pre-stroke mRS scores, and process of care.

methodsWe used data from a large, UK clinical registry. For analysis of validity, we compared pre-stroke mRS against other markers of pre-stroke function (age, comorbidity index, care needs). For analysis of prognostic accuracy, we described univariable and multivariable models comparing pre-stroke mRS and other prognostic variables against a variety of outcomes (early and late mortality, length of stay, institutionalization, incident complications). Finally, we described association of pre-stroke mRS and components of evidence-based stroke care (early neuroimaging, admission to stroke unit, assessment of swallow).

resultsWe analyzed data of 2,491 stroke patients. Concurrent validity analyses suggested statistically significant, but modest correlations between pre-stroke mRS and chosen variables (rho >0.40;

conclusionResults suggest that pre-stroke mRS has some concurrent validity and is a robust predictor of prognosis. This association is not explained by the influence of pre-stroke mRS on care pathways.

Indexed as

complicationsdisabilitymodified Rankin scaleoutcomeprognosisstroke

Identifiers

PMID28659859
PMCPMC5468801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.